PFE vs. CELG: Which is Cheaper?

[cnbc 3000057659]

Pfizer may have a lower multiple than Celgene, says Mad Money’s Cramer, but it also has much slower growth, which is why PFE is expensive at these levels, and CELG is dirt cheap versus its prospect.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.